Mivtachim The Workers Social Insurance Fund’s Protalix BioTherapeutics PLX Stock Holding History

Mivtachim The Workers Social Insurance Fund’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-61,868	Closed	-$730K	–	27
2015 Q3	$730K	Hold	61,868	–	–	0.07%	22
2015 Q2	$1.21M	Hold	61,868	–	–	0.11%	23
2015 Q1	$1.1M	Sell	61,868 -8,476	-12%	-$166K	0.09%	25
2014 Q4	$1.29M	Hold	70,344	–	–	0.12%	24
2014 Q3	$1.7M	Hold	70,344	–	–	0.18%	22
2014 Q2	$2.57M	Hold	70,344	–	–	0.31%	13
2014 Q1	$3.22M	Buy	70,344 +13,688	+24%	+$639K	0.34%	12
2013 Q4	$2.2M	Buy	+56,656	New	+$2.39M	0.17%	16

Other funds holding PLX

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Mivtachim The Workers Social Insurance Fund's PLX Position: Q4 2015 in Review

Mivtachim The Workers Social Insurance Fund sold out of Protalix BioTherapeutics (PLX) in Q4 2015, closing a stake of 61,868 shares — an estimated $730K sold.

Mivtachim The Workers Social Insurance Fund first reported a position in PLX in Q4 2013 and held it in 8 quarters. The position peaked at $3.22M in Q1 2014. 31 funds tracked by Wall St. Rank hold PLX as of Q4 2015.

Mivtachim The Workers Social Insurance Fund reported no remaining Protalix BioTherapeutics position as of Q4 2015 after selling out during the quarter.
Mivtachim The Workers Social Insurance Fund sold 61,868 Protalix BioTherapeutics shares in Q4 2015, an estimated $730K.
Mivtachim The Workers Social Insurance Fund first reported a position in Protalix BioTherapeutics in Q4 2013 and held it in 8 quarters.
Mivtachim The Workers Social Insurance Fund's Protalix BioTherapeutics position peaked at $3.22M in Q1 2014.
31 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q4 2015.

Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q4 2015, filed 1 Feb 2016.